Trademark Encyclopedia

Information about trademarks

Search for trademarks:

• 0
• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• A
• B
• C
• D
• E
• F
• G
• H
• I
• J
• K
• L
• M
• N
• O
• P
• Q
• R
• S
• T
• U
• V
• W
• X
• Y
• Z

Table of contents:

• Document 78629089 overview
• GOODS AND/OR SERVICES CLASS
• PROSECUTION HISTORY
• Document 77712756 overview
• GOODS AND/OR SERVICES CLASS
• PROSECUTION HISTORY

---

---

Trademark domain
name	is free?
prolacria.com

The "PROLACRIA" trademark, serial number 78629089 , was filed on 12th of May 2005 with a mark drawing code of 4000 and its transaction date is 78629089. Since 31st of December 2009, the document can be found in the L70 law office in the publication and issue section. The employee responsible is STEEL, ALYSSA PALADINO and the date it was published for opposition on 01/31/2006. The status of this trademark was checked last on 04/16/2009.

The corresponded responsible for this trademark is ALLERGAN, INC., located at 2525 DUPONT DR, IRVINE, CA 92612-1599, .

The state or country where the trademark was organized is CA by Allergan, Inc.. The legal entity type behing it is a Corporation, located at 2525 Dupont Drive, Irvine, CA zip 92612.

GOODS AND/OR SERVICES
International Class - 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
U.S. Class	052 - Detergents and Soaps
Class Status	8 - Abandoned
Status Date	04/16/2009
Primary Code	005
Goods codes
GS0051	Ophthalmic preparations for the treatment of dry eye

PROSECUTION HISTORY
Date	Description	Type	Code
07/16/2007	EXTENSION 2 GRANTED	S	EX2G - EXTENSION 2 GRANTED
03/28/2007	EXTENSION 2 FILED	S	EXT2 - EXTENSION 2 FILED
04/16/2009	ABANDONMENT NOTICE MAILED - AFTER PUBLICATION	O - Outgoing Correspondence	MAB5 - ABANDONMENT NOTICE MAILED - AFTER PUBLICATION
04/16/2009	ABANDONMENT - AFTER PUBLICATION	O - Outgoing Correspondence	ABN5 - ABANDONMENT - AFTER PUBLICATION
04/15/2009	TEAS EXPRESS ABANDONMENT RECEIVED	I - Incoming Correspondence	EXAR - TEAS EXPRESS ABANDONMENT RECEIVED
09/25/2008	EXTENSION 5 GRANTED	S	EX5G - EXTENSION 5 GRANTED
09/23/2008	EXTENSION 5 FILED	S	EXT5 - EXTENSION 5 FILED
09/24/2008	CASE ASSIGNED TO INTENT TO USE PARALEGAL	A - Allowance for Publication	AITU
09/23/2008	TEAS EXTENSION RECEIVED	I - Incoming Correspondence	EEXT - TEAS EXTENSION RECEIVED
04/10/2008	EXTENSION 4 GRANTED	S	EX4G - EXTENSION 4 GRANTED
03/27/2008	EXTENSION 4 FILED	S	EXT4 - EXTENSION 4 FILED
03/27/2008	TEAS EXTENSION RECEIVED	I - Incoming Correspondence	EEXT - TEAS EXTENSION RECEIVED
10/12/2007	EXTENSION 3 GRANTED	S	EX3G - EXTENSION 3 GRANTED
10/02/2007	EXTENSION 3 FILED	S	EXT3 - EXTENSION 3 FILED
10/02/2007	TEAS EXTENSION RECEIVED	I - Incoming Correspondence	EEXT - TEAS EXTENSION RECEIVED
03/28/2007	TEAS EXTENSION RECEIVED	I - Incoming Correspondence	EEXT - TEAS EXTENSION RECEIVED
12/07/2006	EXTENSION 1 GRANTED	S	EX1G - EXTENSION 1 GRANTED
10/20/2006	EXTENSION 1 FILED	S	EXT1 - EXTENSION 1 FILED
10/20/2006	TEAS EXTENSION RECEIVED	I - Incoming Correspondence	EEXT - TEAS EXTENSION RECEIVED
04/25/2006	NOA MAILED - SOU REQUIRED FROM APPLICANT	O - Outgoing Correspondence	NOAM - NOTICE OF ALLOWANCE-MAILED
01/31/2006	PUBLISHED FOR OPPOSITION	A - Allowance for Publication	PUBO - PUBLISHED FOR OPPOSITION
01/11/2006	NOTICE OF PUBLICATION	O - Outgoing Correspondence	NPUB - NOTICE OF PUBLICATION
12/21/2005	LAW OFFICE PUBLICATION REVIEW COMPLETED	O - Outgoing Correspondence	PREV - LAW OFFICE PUBLICATION REVIEW COMPLETED
12/16/2005	ASSIGNED TO LIE	A - Allowance for Publication	ALIE - ASSIGNED TO LIE
12/12/2005	APPROVED FOR PUB - PRINCIPAL REGISTER	P	CNSA - APPROVED FOR PUB - PRINCIPAL REGISTER
12/08/2005	ASSIGNED TO EXAMINER	D - Assigned to Examiner	DOCK - ASSIGNED TO EXAMINER
05/20/2005	NEW APPLICATION ENTERED IN TRAM	I - Incoming Correspondence	NWAP - NEW APPLICATION ENTERED IN TRAM

Some parts © 2024 Advameg, Inc.